Prize for Diabetology 2021-2022

Novo Nordisk is a global healthcare company, founded in 1923 and headquartered just outside Copenhagen, Denmark. 

We employ more than 45,000 people in 80 offices around the world, and market our products in 169 countries

Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity, rare blood and rare endocrine diseases. We do so by pioneering scientific breakthroughs, expanding access to our medicines and working to prevent and ultimately cure the diseases we treat.



  • Holder of a medical degree
  • Younger than 45 in December 2021
  • Attached to a Belgian or Luxembourg institution



  • Send an email to
  • Include coordinates of the candidate and project title

Deadline submission final thesis

February 28, 2022


Last quarter of 2022


2012: Prof. Dr. Philips - CHU De Liège

2014: Prof. Dr. Martens - AZ Delta Roeselare

2016: Prof. Dr. De Block - UZ Antwerpen

2018: Prof. Dr. De Leu - UZ Brussel

2020 : Prof. Dr. Benhalima - UZ Leuven